338 filings
Page 7 of 17
8-K
bnzc0ka6rab5us
10 Jan 20
Sorrento Therapeutics, Inc. Received Non-Binding Acquisition Proposal
7:00am
8-K
a6a84d6
20 Dec 19
SORRENTO Announces Dr. Robin Smith as new member of the board of directors
4:09pm
8-K
33ukxj8 em81
9 Dec 19
SORRENTO Announces new board member
7:00am
8-K
o3h9pee
25 Nov 19
Sorrento Therapeutics, Inc. Received and Rejected Unsolicited All Cash Acquisition Proposal
7:00am
8-K
52o2w0 4ismfwsuypl
9 Oct 19
SORRENTO THERAPEUTICS ANNOUNCES Closing of $25 MILLION REGISTERED DIRECT OFFERING
11:46am
8-K
2utgdeuuupure
8 Oct 19
Sorrento Therapeutics Announces $25 Million Registered Direct Offering
4:18pm
8-K
6ake066mzawkkl5mh3i
1 Oct 19
Entry into a Material Definitive Agreement
4:32pm
8-K
wtw rypnjcae1
1 Oct 19
Entry into a Material Definitive Agreement
4:28pm
8-K
icute6aeo0
23 Sep 19
Scilex Holding ANNOUNCEs Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering
7:00am
8-K
6j4 l95qsmjd
23 Sep 19
Departure of Directors or Certain Officers
6:06am
8-K
udx1v
12 Aug 19
Other Events
10:10am
8-K
v5orli6j2m stgorc9qw
12 Aug 19
Other Events
10:07am
8-K
81swc13
2 Jul 19
Other Events
12:52pm
8-K
av5t5as
28 Jun 19
Entry into a Material Definitive Agreement
5:17pm
8-K
p27tfp
20 Jun 19
Other Events
7:00am
8-K
5bs9qyse o8
19 Jun 19
Sorrento PROVIDEs updates ON CD38 IMMUNOTHERApiEs and implementation of disruptive GMP manufacturing for “Off-the-shelf” cell therapy
7:00am
8-K
9i6x 0hc14
17 Jun 19
Termination of a Material Definitive Agreement
4:40pm
8-K
8owqfl88 t6h11kw2m
17 Jun 19
Other Events
9:22am
8-K
xg0izy6p1fn
12 Jun 19
Sorrento To Explore Potential Initial Public Offering of Scilex Holding Company
7:00am
8-K
hixgms964a
5 Jun 19
Scilex Holding ANNOUNCEs strong Ztlido sales growth after successful post-merger integration
7:00am